APA

Jatoi A., Dakhil S. R., Foster N. R., Ma C., Rowland K. M., Moore D. F., Jaslowski A. J., Thomas S. P., Hauge M. D., Flynn P. J., Stella P. J. & Alberts S. R. (20080703). Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chicago

Jatoi Aminah, Dakhil Shaker R, Foster Nathan R, Ma Cynthia, Rowland Kendrith M, Moore Dennis F, Jaslowski Anthony J, Thomas Sachdev P, Hauge Mark D, Flynn Patrick J, Stella Philip J and Alberts Steven R. 20080703. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Harvard

Jatoi A., Dakhil S. R., Foster N. R., Ma C., Rowland K. M., Moore D. F., Jaslowski A. J., Thomas S. P., Hauge M. D., Flynn P. J., Stella P. J. and Alberts S. R. (20080703). Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

MLA

Jatoi Aminah, Dakhil Shaker R, Foster Nathan R, Ma Cynthia, Rowland Kendrith M, Moore Dennis F, Jaslowski Anthony J, Thomas Sachdev P, Hauge Mark D, Flynn Patrick J, Stella Philip J and Alberts Steven R. Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B). : Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 20080703.